L. rhamnosus Rosell®-11 + L. helveticus Rosell®-52

Diarrhea, Antibiotic-Associated Diarrhea, H. pylori eradication therapy, Atopic Dermatitis

  • Lactose intolerance in children and adults
    • 2B CFU
  • Atopic Dermatitis in children
    • 2B CFU
  • Antibiotic-associated diarrhea in children and in adults
    • from 1B to 12B depending on age
  • Adjunct to physician-supervised therapy in children and adults with Helicobacter pylori infections
    • 4 to 6B CFU
  • Maintain a healthy microflora in pregnant women undergoing antibiotic therapy
    • 4 to 6B CFU

Lacidofil®, a proprietary combination of Lactobacillus rhamnosus Rosell®-11 and Lactobacillus helveticus Rosell®-52, was developed more than 30 years ago by Lallemand Health Solutions to support and maintain the digestive microflora. Both the finished product formulation and the individual strains have been extensively used and researched worldwide over the years.